Drug Trial Radar · NCT01811732
Delafloxacin Versus Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Last checked: Nov 20, 2026Latest source record: Sep 27, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
660
Actual
Start
Apr 2013
Primary completion
Jul 2014
Study completion Jul 2014
Sponsor
- Lead sponsor
- Melinta Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Mar 15, 2013
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study was designed to evaluate the efficacy of delafloxacin patients with acute bacterial skin and soft tissue infections (ABSSSI).
Conditions
- Skin and Subcutaneous Tissue Bacterial Infections
Interventions
DelafloxacinDrug
Delafloxacin
VancomycinDrug
Vancomycin
AztreonamDrug
Aztreonam
PlaceboDrug
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Objective Response at 48 to 72 Hours (FDA Primary Endpoint)Time frame: 48 to 72 hours after starting treatment
Locations
50 sites in 7 countries. Site status is shown where the registry gives one.
Melinta Investigational Site
Montgomery, Alabama
Melinta Investigational Site
Anaheim, California
Melinta Investigational Site
Chula Vista, California
Melinta Investigational Site
La Mesa, California
Melinta Investigational Site
Long Beach, California
Melinta Investigational Site
Los Angeles, California
Melinta Investigational Site
Modesto, California
Melinta Investigational Site
Oceanside, California
Melinta Investigational Site
Pasadena, California
Melinta Investigational Site
Stockton, California
Melinta Investigational Site
Miramar, Florida
Melinta Investigational Site
Minneapolis, Minnesota
Melinta Investigational Site
Butte, Montana
Melinta Investigational Site
Las Vegas, Nevada
Melinta Investigational Site
Somers Point, New Jersey
Melinta Investigational Site
Smyrna, Tennessee
Melinta Investigational Site
Richmond, Texas
Melinta Investigational Site
Slavonski Brod, Croatia
Melinta Investigational Site
Zagreb, Croatia
Melinta Investigational Site
Zagreb, Croatia
Melinta Investigational Site
Haifa, Israel
Melinta Investigational Site
Haifa, Israel
Melinta Investigational Site
Kfar Saba, Israel
Melinta Investigational Site
Nazareth, Israel
Melinta Investigational Site
Safed, Israel
Melinta Investigational Site
Tel Aviv, Israel
Melinta Investigational Site
Daugavpils, Latvia
Melinta Investigational Site
Liepāja, Latvia
Melinta Investigational Site
Riga, Latvia
Melinta Investigational Site
Riga, Latvia
Melinta Investigational Site
Valmiera, Latvia
Melinta Investigational Site
Moscow, Russia
Melinta Investigational Site
Perm, Russia
Melinta Investigational Site
Saint Petersberg, Russia
Melinta Investigational Site
Vsevolozhsk, Russia
Melinta Investigational Site
Barcelona, Spain
Melinta Investigational Site
Barcelona, Spain
Melinta Investigational Site
Granada, Spain
Melinta Investigational Site
Málaga, Spain
Melinta Investigational Site
Valencia, Spain
Showing 40 of 50 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.